English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/36548
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

GLP-1(7-36)-amide and Exendin-4 Stimulate the HPA Axis in Rodents and Humans

AuthorsGil-Lozano, Manuel; Pérez-Tilve, Diego; Álvarez-Crespo, Mayte; Martís, Aurelio; Fernández García, Ana María ; Catalina, Pablo A. F.; González-Matías, Lucas C.; Mallo, F.
Issue Date2010
PublisherEndocrine Society
CitationEndocrinology 151(6):2629-2640 (2010)
AbstractGlucagon-like peptide-1 (GLP-1) is a potent insulinotropic peptide expressed in the gut and brain, which is secreted in response to food intake. The levels of GLP-1 within the brain have been related to the activity of the hypothalamic-pituitary-adrenal (HPA) axis, and hence, this peptide might mediate some responses to stress. Nevertheless, there is little information regarding the effects of circulating GLP-1 on the neuroendocrine control of HPA activity. Here, we have studied the response of corticoadrenal steroids to the peripheral administration of GLP-1 (7-36)-amide and related peptides [exendin (Ex)-3, Ex-4, and Ex-4(3-39)] in rats, mice, and humans. GLP-1 increases circulating corticosterone levels in a time-dependent manner, both in conscious and anaesthetized rats, and it has also increased aldosterone levels. Moreover, GLP-1 augmented cortisol levels in healthy subjects and diabetes mellitus (DM)-1 patients. The effects of GLP-1/Ex-4 on the HPA axis are very consistent after distinct means of administration (intracerebroventricular, iv, and ip), irrespective of the metabolic state of the animals (fasting or fed ad libitum), and they were reproduced by different peptides in this family, independent of glycaemic changes and their insulinotropic properties. Indeed, these effects were also observed in diabetic subjects (DM-1 patients) and in the DM-1 streptozotocin-rat or DM-2 muscle IGF-I receptor-lysine-arginine transgenic mouse animal models. The mechanisms whereby circulating GLP-1 activates the HPA axis remain to be elucidated, although an increase in ACTH after Ex-4 and GLP-1 administration implicates the central nervous system or a direct effect on the pituitary. Together, these findings suggest that GLP-1 may play an important role in regulating the HPA axis
Description12 pages, 7 figures, 2 tables. - PMID: 20363879 [PubMed - indexed for MEDLINE] Free Article
Publisher version (URL)http://endo.endojournals.org/content/151/6/2629.full.pdf+html
URIhttp://hdl.handle.net/10261/36548
DOI10.1210/en.2009-0915
ISSN0013-7227
E-ISSN1945-7170
Appears in Collections:(IC) Artículos
Files in This Item:
File Description SizeFormat 
Fernandez,A.Endocrinology-2010.pdf1,29 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.